Global Oncology Informatics Market: Focus on Competitive Landscape, Products, End Users, Regional Adoption - Analysis and Forecast, 2019-2025
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
Key Questions Answered in the Report:
The Global Oncology Informatics Market Report by BIS Research projects the market to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025. The market has evolved dramatically with the increasing cost of cancer care, emphasis on reduction in medical errors and readmission rates, growing number of cancer patients, and rising adoption of oncology specific EHRs.
Despite the benefits of these software solutions, the major challenges in the market are lack of shortage of medical oncologists, high upfront cost of installation of these solutions, lack of interoperability within the system, and data security concerns. Some of the major opportunities for the key vendors in the market could be integration of oncology informatics with Blockchain technology, investment opportunities in emerging economies such as India, China, and Brazil, collaboration with precision medicine providers, and introduction of systems in different languages.
Expert Quote
“Pharmaceutical companies and life science companies are the major end users of the oncology informatics market in terms of revenue share. The pharmaceutical companies market share is expected to increase up -to $2.04 billion, while life science companies’ share is estimated to be $1.27 billion by the end of 2025. However, the usage of the solutions is expected to increase in hospitals and research centers in order to streamline the workflow of the facilities and improve the quality of care.”
Scope of the Market Intelligence on Global Oncology Informatics Market
The purpose of this study is to gain a holistic view of the global oncology informatics market in terms of various influencing factors such as regional adoption trends, product types, and end users.
The scope of this report constitutes of an in-depth study of the global oncology informatics market, including a thorough analysis of the products in the market as well as their adoption spanning different geographical regions. The market has been chiefly segmented into component type, end user, and region. The report provides the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
Market Segmentation
The Global Oncology Informatics Market can be segmented on the basis of ccomponent type, end user, and region. As of 2018, oncology EHRs accounts for $2.14 billion and is expected to reach a value of $3.24 billion by the end of 2025. In terms of growth, the end users’ academic institutes and research centers segment is expected to grow at the highest CAGR of 7.69% during the forecast period.
As of 2018, North America is the largest shareholder for the overall market and is expected to reach the value of $2.92 billion by the end of 2025 growing with the CAGR of 6.02% during the forecast period. However, a higher growth rate can be expected from the Asia-Pacific region, considering its improving healthcare infrastructure, overburdened healthcare system, and focus of ASEAN countries to be recognized as medical tourism destination.
Although the adoption rate of the oncology informatics solutions has been moderate, the potential that lies in them is immense. The integration of oncology informatics solutions in the healthcare facility will not only improve customer experience but also help hospitals to provide improved quality of healthcare. To make the entire oncology healthcare system more efficient, the oncology solutions can be integrated across various stakeholders, namely pharmaceutical companies, life science companies, contract research organizations (CROs), academic institutes and research centers, and hospitals and diagnostics laboratories.
Key Companies in the Global Oncology Informatics Market
Some of the major key players in the global oncology informatics market include Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc. , PerkinElmer, Inc., RELX Group, Sirenas LLC, UnitedHealth Group, Inc. , and Varian Medical Systems, Inc.
Key Questions Answered in the Report:
- How are oncology informatics solutions positioned to save healthcare expenditure annually? How can these solutions help in reducing healthcare expenditure for developed economies such as North America and Europe?
- How are oncology informatics solutions helping in changing the business model of healthcare delivery?
- What are the major developments such as product launches, mergers and acquisitions, collaborations, and partnerships taking place in the market, and how are they changing the overall dynamics of the global oncology informatics market?
- What are the major pricing strategies employed by the vendors that can significantly put pricing pressure on the competitors?
- What is the current user base for the leading oncology informatics solutions vendors in the market?
- What are the technological and regional trends pertaining to the global oncology informatics market?
- What is the growth potential of the global oncology informatics market in North America, Europe, Asia-Pacific, and Rest-of-the-World?
The Global Oncology Informatics Market Report by BIS Research projects the market to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025. The market has evolved dramatically with the increasing cost of cancer care, emphasis on reduction in medical errors and readmission rates, growing number of cancer patients, and rising adoption of oncology specific EHRs.
Despite the benefits of these software solutions, the major challenges in the market are lack of shortage of medical oncologists, high upfront cost of installation of these solutions, lack of interoperability within the system, and data security concerns. Some of the major opportunities for the key vendors in the market could be integration of oncology informatics with Blockchain technology, investment opportunities in emerging economies such as India, China, and Brazil, collaboration with precision medicine providers, and introduction of systems in different languages.
Expert Quote
“Pharmaceutical companies and life science companies are the major end users of the oncology informatics market in terms of revenue share. The pharmaceutical companies market share is expected to increase up -to $2.04 billion, while life science companies’ share is estimated to be $1.27 billion by the end of 2025. However, the usage of the solutions is expected to increase in hospitals and research centers in order to streamline the workflow of the facilities and improve the quality of care.”
Scope of the Market Intelligence on Global Oncology Informatics Market
The purpose of this study is to gain a holistic view of the global oncology informatics market in terms of various influencing factors such as regional adoption trends, product types, and end users.
The scope of this report constitutes of an in-depth study of the global oncology informatics market, including a thorough analysis of the products in the market as well as their adoption spanning different geographical regions. The market has been chiefly segmented into component type, end user, and region. The report provides the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.
Market Segmentation
The Global Oncology Informatics Market can be segmented on the basis of ccomponent type, end user, and region. As of 2018, oncology EHRs accounts for $2.14 billion and is expected to reach a value of $3.24 billion by the end of 2025. In terms of growth, the end users’ academic institutes and research centers segment is expected to grow at the highest CAGR of 7.69% during the forecast period.
As of 2018, North America is the largest shareholder for the overall market and is expected to reach the value of $2.92 billion by the end of 2025 growing with the CAGR of 6.02% during the forecast period. However, a higher growth rate can be expected from the Asia-Pacific region, considering its improving healthcare infrastructure, overburdened healthcare system, and focus of ASEAN countries to be recognized as medical tourism destination.
Although the adoption rate of the oncology informatics solutions has been moderate, the potential that lies in them is immense. The integration of oncology informatics solutions in the healthcare facility will not only improve customer experience but also help hospitals to provide improved quality of healthcare. To make the entire oncology healthcare system more efficient, the oncology solutions can be integrated across various stakeholders, namely pharmaceutical companies, life science companies, contract research organizations (CROs), academic institutes and research centers, and hospitals and diagnostics laboratories.
Key Companies in the Global Oncology Informatics Market
Some of the major key players in the global oncology informatics market include Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc. , PerkinElmer, Inc., RELX Group, Sirenas LLC, UnitedHealth Group, Inc. , and Varian Medical Systems, Inc.
Executive Summary
1 PRODUCT DEFINITION
1.1 Oncology Information System (OIS)
1.2 Other Systems Used in Oncology Informatics
2 MARKET OVERVIEW
2.1 Current Market Scenario
2.2 The Role of EHRs in Oncology
2.3 Need for Integration of EHR and OIS
2.4 Pricing Models for EHR Oncology Systems
2.5 Consumer Preference for Different Pricing Models
3 SCOPE OF THE REPORT
4 RESEARCH METHODOLOGY
4.1 Research Methodology
5 INDUSTRY ANALYSIS
5.1 Industry Trends
5.2 Regulatory Framework
5.2.1 Regulatory Framework in North America
5.2.2 Regulatory Framework in Europe
5.2.3 Regulatory Framework in Asia-Pacific
5.3 Patent Analysis
6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Key Developments and Strategies
6.2.1 Partnerships and Collaborations
6.2.2 Product Launches and Upgradations
6.2.3 Mergers and Acquisitions
6.2.4 Business Expansion
6.2.5 Others
6.3 Product Mapping Analysis
7 MARKET DYNAMICS
7.1 Market Drivers
7.1.1 Increasing Cost of Cancer Care
7.1.2 Emphasis on Reduction in Medical Errors and Readmission Rates
7.1.3 Growing Number of Cancer Patients
7.1.4 Rising Adoption of Oncology-Specific EHRs
7.2 Market Restraints
7.2.1 Shortage of Medical Oncologists
7.2.2 High Cost of Implementation of Oncology-Specific EMRs
7.2.3 Lack of Interoperability Among HIT Systems
7.2.4 Data Security Concerns
7.3 Market Opportunities
7.3.1 Integration of Oncology Health Informatics with Blockchain
7.3.2 Investment Opportunities in Emerging Markets such as India, China, and Brazil
7.3.3 Collaborations with Precision Medicine Providers
7.3.4 Introduction of Solutions in Different Languages
8 GLOBAL ONCOLOGY INFORMATICS MARKET (BY TYPE)
8.1 Overview
8.2 Electronic Health Records (EHRs)
8.2.1 Overview
8.2.2 Role of EHR in Oncology
8.2.3 Features of Oncology EHR
8.2.4 Oncology EHR: Product Description
8.2.5 Global Installation of Oncology EHR
8.3 Population Health Management (PHM)
8.3.1 Overview
8.3.2 Role of PHM in Oncology
8.3.3 Features of Oncology PHM
8.3.4 Oncology PHM: Product Description
8.4 Clinical Decision Support System (CDSS)
8.4.1 Overview
8.4.2 Role of CDSS in Oncology
8.4.3 Features of Oncology CDSS
8.4.4 Oncology CDSS: Product Description
8.4.5 Application of CDSS in Oncology
8.4.6 Global Installation of Oncology CDSS
8.5 Drug Discovery and Development Informatics
8.5.1 Overview
8.5.2 Role of Drug Discovery and Development Informatics in Oncology
8.5.3 Drug Discovery and Development Informatics in Oncology: Product Description
8.5.4 Application of Drug Discovery and Development Informatics in Oncology
8.5.5 Global Installation of Oncology Drug Discovery and Development Informatics
8.6 Image Analytics
8.6.1 Overview
8.6.2 Role and Benefits of Image Analytics in Oncology
8.6.3 Oncology Image Analytics: Product Description
8.6.4 Application of Image Analytics in Oncology
9 GLOBAL ONCOLOGY INFORMATICS MARKET (BY END USER)
9.1 Overview
9.2 Pharmaceutical Industry
9.3 Life Science Industry
9.4 Contract Research Organizations (CROs)
9.5 Academic Institutes and Research Centers
9.6 Others (Hospitals and Other Care Facilities)
10 GLOBAL ONCOLOGY INFORMATICS MARKET (BY REGION)
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.1.1 Companies in the U.S. Oncology Informatics Market
10.2.1.2 Government Initiatives
10.2.1.3 CDSS in the U.S. Oncology Informatics Market
10.2.1.4 Market Dynamics
10.2.2 Canada
10.2.2.1 Degree of Adoption of EHRs
10.2.2.2 Local Oncology Informatics Products
10.2.2.3 Market Dynamics
10.3 Europe
10.3.1 Germany
10.3.1.1 Degree of Adoption of HIT Solutions
10.3.1.2 Factors Impacting Oncology Informatics Market in Germany
10.3.1.3 Market Dynamics
10.3.2 U.K.
10.3.2.1 Degree of Adoption of Oncology Informatics
10.3.2.2 Market Dynamics
10.3.3 France
10.3.3.1 Degree of Adoption of EHR
10.3.3.2 Status of Oncology Informatics
10.3.3.3 Market Dynamics
10.3.4 Spain
10.3.4.1 Degree of Adoption of Oncology Informatics
10.3.4.2 Market Dynamics
10.3.5 Italy
10.3.5.1 Degree of Adoption of HIT Solutions
10.3.5.2 Factors Impacting Oncology Informatics Market in Italy
10.3.5.3 Partnerships
10.3.5.4 Market Dynamics
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 South Korea
10.4.1.1 Degree of Adoption of HIT Solutions
10.4.1.2 Oncology Informatics in South Korea
10.4.1.3 Market Dynamics
10.4.2 Japan
10.4.2.1 Degree of Adoption of HIT Solutions
10.4.2.2 Implementation of Oncology Informatics
10.4.2.3 Market Dynamics
10.4.3 China
10.4.3.1 Degree of Adoption of HIT Solutions
10.4.3.2 Partnerships
10.4.3.3 Market Dynamics
10.4.4 India
10.4.4.1 Degree of Adoption of HIT Solutions
10.4.4.2 Initiatives for Oncology Informatics
10.4.4.3 Market Dynamics
10.4.5 Australia
10.4.5.1 Degree of Adoption of EHR
10.4.5.2 Market Dynamics
10.4.6 Rest-of-Asia-Pacific
10.4.6.1 Degree of Adoption of HIT Solutions in New Zealand
10.4.6.2 Degree of Adoption of HIT Solutions in Malaysia
10.4.6.3 Degree of Adoption of HIT Solutions in Singapore
10.4.6.4 Market Dynamics
10.5 Rest-of-the-World
10.5.1 U.A.E.
10.5.1.1 Degree of Adoption of HIT Solutions
10.5.1.2 Challenges
10.5.1.3 Market Dynamics
10.5.2 Saudi Arabia
10.5.2.1 Degree of Adoption of HIT Solutions
10.5.2.2 Market Opportunities
10.5.3 Brazil
10.5.4 Mexico
10.5.5 South Africa
10.5.6 Rest-of-Rest-of-the-World
11 COMPANY PROFILES
11.1 Cerner Corporation
11.1.1 Company Overview
11.1.2 Role of Cerner Corporation in Global Oncology Informatics Market
11.1.3 Product Offerings
11.1.4 Financials
11.1.5 Key Insights about Financial Health of the Company
11.1.6 Recent Developments
11.1.7 SWOT Analysis
11.2 Change Healthcare
11.2.1 Company Overview
11.2.2 Role of Change Healthcare in Global Oncology Informatics Market
11.2.3 Product Offerings
11.2.4 Recent Key Developments
11.2.5 SWOT Analysis
11.3 Elekta AB
11.3.1 Company Overview
11.3.2 Role of Elekta AB in Global Oncology Informatics Market
11.3.3 Product Offerings
11.3.4 Financials
11.3.5 Key Insights about Financial Health of the Company
11.3.6 Recent Key Developments
11.3.7 SWOT Analysis
11.4 F. Hoffmann-La Roche Ltd
11.4.1 Company Overview
11.4.2 Role of F. Hoffmann-La Roche Ltd in Global Oncology Informatics Market
11.4.3 Product Offering
11.4.4 Financials
11.4.5 Key Insights about Financial Health of the Company
11.4.6 Recent Developments
11.4.7 SWOT Analysis
11.5 Hologic, Inc.
11.5.1 Company Overview
11.5.2 Role of Hologic, Inc. in Global Oncology Informatics Market
11.5.3 Product Offerings
11.5.4 Financials
11.5.5 Key Insights about Financial Health of the Company
11.5.6 Recent Developments
11.5.7 SWOT Analysis
11.6 IBM Corporation
11.6.1 Company Overview
11.6.2 Role of IBM Corporation in Global Oncology Informatics Market
11.6.3 Product Offerings
11.6.4 Financials
11.6.5 Key Insights about Financial Health of the Company
11.6.6 Recent Developments
11.6.7 SWOT Analysis
11.7 Inspirata, Inc.
11.7.1 Company Overview
11.7.2 Role of Inspirata, Inc. in Global Oncology Informatics Market
11.7.3 Product Offerings
11.7.4 Recent Key Developments
11.7.5 SWOT Analysis
11.8 Koninklijke Philips N.V.
11.8.1 Company Overview
11.8.2 Role of Koninklijke Philips N.V. in Global Oncology Informatics Market
11.8.3 Product Offerings
11.8.4 Financials
11.8.5 Key Insights about Financial Health of the Company
11.8.6 Recent Developments
11.8.7 SWOT Analysis
11.9 Laboratory Corporation of America Holdings
11.9.1 Company Overview
11.9.2 Role of Laboratory Corporation of America Holdings in Global Oncology Informatics Market
11.9.3 Product Offerings
11.9.4 Financials
11.9.5 Recent Key Developments
11.9.6 SWOT Analysis
11.10 McKesson Corporation
11.10.1 Company Overview
11.10.2 Role of McKesson Corporation in Global Oncology Informatics Market
11.10.3 Product Offerings
11.10.4 Financials
11.10.5 Key Insights about Financial Health of the Company
11.10.6 Recent Development
11.10.7 SWOT Analysis
11.11 MIM Software, Inc.
11.11.1 Company Overview
11.11.2 Role of MIM Software, Inc. in Global Oncology Informatics Market
11.11.3 Product Offerings
11.11.4 Recent Key Developments
11.11.5 SWOT Analysis
11.12 Oncology Analytics, Inc
11.12.1 Company Overview
11.12.2 Role of Oncology Analytics, Inc.in Global Oncology Informatics Market
11.12.3 Product Offerings
11.12.4 Recent Developments
11.12.5 SWOT Analysis
11.13 PerkinElmer, Inc.
11.13.1 Company Overview
11.13.2 Role of PerkinElmer Inc, in Global Oncology Informatics Market
11.13.3 Product Offerings
11.13.4 Financials
11.13.5 Key Insights about Financial Health of the Company
11.13.6 Recent Developments
11.13.7 SWOT Analysis
11.14 RELX Group
11.14.1 Company Overview
11.14.2 Role of RELX Group in Global Oncology Informatics Market
11.14.3 Product Offerings
11.14.4 Financials
11.14.5 Recent Developments
11.14.6 SWOT Analysis
11.15 Sirenas, LLC
11.15.1 Company Overview
11.15.2 Role of Sirenas, LLC in Global Oncology Informatics Market
11.15.3 Product Offerings
11.15.4 Recent Key Developments
11.15.5 SWOT Analysis
11.16 UnitedHealth Group, Inc
11.16.1 Company Overview
11.16.2 Role of UnitedHealth Group, Inc in Global Oncology Informatics Market
11.16.3 Product Offerings for Oncology Informatics Market
11.16.4 Financials
11.16.5 Recent Developments
11.16.6 SWOT Analysis
11.17 Varian Medical Systems, Inc
11.17.1 Company Overview
11.17.2 Role of Varian Medical Systems, Inc. in Global Oncology Informatics Market
11.17.3 Product Offerings
11.17.4 Financials
11.17.5 Key Insights about Financial Health of the Company
11.17.6 Recent Developments
11.17.7 SWOT Analysis
1 PRODUCT DEFINITION
1.1 Oncology Information System (OIS)
1.2 Other Systems Used in Oncology Informatics
2 MARKET OVERVIEW
2.1 Current Market Scenario
2.2 The Role of EHRs in Oncology
2.3 Need for Integration of EHR and OIS
2.4 Pricing Models for EHR Oncology Systems
2.5 Consumer Preference for Different Pricing Models
3 SCOPE OF THE REPORT
4 RESEARCH METHODOLOGY
4.1 Research Methodology
5 INDUSTRY ANALYSIS
5.1 Industry Trends
5.2 Regulatory Framework
5.2.1 Regulatory Framework in North America
5.2.2 Regulatory Framework in Europe
5.2.3 Regulatory Framework in Asia-Pacific
5.3 Patent Analysis
6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Key Developments and Strategies
6.2.1 Partnerships and Collaborations
6.2.2 Product Launches and Upgradations
6.2.3 Mergers and Acquisitions
6.2.4 Business Expansion
6.2.5 Others
6.3 Product Mapping Analysis
7 MARKET DYNAMICS
7.1 Market Drivers
7.1.1 Increasing Cost of Cancer Care
7.1.2 Emphasis on Reduction in Medical Errors and Readmission Rates
7.1.3 Growing Number of Cancer Patients
7.1.4 Rising Adoption of Oncology-Specific EHRs
7.2 Market Restraints
7.2.1 Shortage of Medical Oncologists
7.2.2 High Cost of Implementation of Oncology-Specific EMRs
7.2.3 Lack of Interoperability Among HIT Systems
7.2.4 Data Security Concerns
7.3 Market Opportunities
7.3.1 Integration of Oncology Health Informatics with Blockchain
7.3.2 Investment Opportunities in Emerging Markets such as India, China, and Brazil
7.3.3 Collaborations with Precision Medicine Providers
7.3.4 Introduction of Solutions in Different Languages
8 GLOBAL ONCOLOGY INFORMATICS MARKET (BY TYPE)
8.1 Overview
8.2 Electronic Health Records (EHRs)
8.2.1 Overview
8.2.2 Role of EHR in Oncology
8.2.3 Features of Oncology EHR
8.2.4 Oncology EHR: Product Description
8.2.5 Global Installation of Oncology EHR
8.3 Population Health Management (PHM)
8.3.1 Overview
8.3.2 Role of PHM in Oncology
8.3.3 Features of Oncology PHM
8.3.4 Oncology PHM: Product Description
8.4 Clinical Decision Support System (CDSS)
8.4.1 Overview
8.4.2 Role of CDSS in Oncology
8.4.3 Features of Oncology CDSS
8.4.4 Oncology CDSS: Product Description
8.4.5 Application of CDSS in Oncology
8.4.6 Global Installation of Oncology CDSS
8.5 Drug Discovery and Development Informatics
8.5.1 Overview
8.5.2 Role of Drug Discovery and Development Informatics in Oncology
8.5.3 Drug Discovery and Development Informatics in Oncology: Product Description
8.5.4 Application of Drug Discovery and Development Informatics in Oncology
8.5.5 Global Installation of Oncology Drug Discovery and Development Informatics
8.6 Image Analytics
8.6.1 Overview
8.6.2 Role and Benefits of Image Analytics in Oncology
8.6.3 Oncology Image Analytics: Product Description
8.6.4 Application of Image Analytics in Oncology
9 GLOBAL ONCOLOGY INFORMATICS MARKET (BY END USER)
9.1 Overview
9.2 Pharmaceutical Industry
9.3 Life Science Industry
9.4 Contract Research Organizations (CROs)
9.5 Academic Institutes and Research Centers
9.6 Others (Hospitals and Other Care Facilities)
10 GLOBAL ONCOLOGY INFORMATICS MARKET (BY REGION)
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.1.1 Companies in the U.S. Oncology Informatics Market
10.2.1.2 Government Initiatives
10.2.1.3 CDSS in the U.S. Oncology Informatics Market
10.2.1.4 Market Dynamics
10.2.2 Canada
10.2.2.1 Degree of Adoption of EHRs
10.2.2.2 Local Oncology Informatics Products
10.2.2.3 Market Dynamics
10.3 Europe
10.3.1 Germany
10.3.1.1 Degree of Adoption of HIT Solutions
10.3.1.2 Factors Impacting Oncology Informatics Market in Germany
10.3.1.3 Market Dynamics
10.3.2 U.K.
10.3.2.1 Degree of Adoption of Oncology Informatics
10.3.2.2 Market Dynamics
10.3.3 France
10.3.3.1 Degree of Adoption of EHR
10.3.3.2 Status of Oncology Informatics
10.3.3.3 Market Dynamics
10.3.4 Spain
10.3.4.1 Degree of Adoption of Oncology Informatics
10.3.4.2 Market Dynamics
10.3.5 Italy
10.3.5.1 Degree of Adoption of HIT Solutions
10.3.5.2 Factors Impacting Oncology Informatics Market in Italy
10.3.5.3 Partnerships
10.3.5.4 Market Dynamics
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 South Korea
10.4.1.1 Degree of Adoption of HIT Solutions
10.4.1.2 Oncology Informatics in South Korea
10.4.1.3 Market Dynamics
10.4.2 Japan
10.4.2.1 Degree of Adoption of HIT Solutions
10.4.2.2 Implementation of Oncology Informatics
10.4.2.3 Market Dynamics
10.4.3 China
10.4.3.1 Degree of Adoption of HIT Solutions
10.4.3.2 Partnerships
10.4.3.3 Market Dynamics
10.4.4 India
10.4.4.1 Degree of Adoption of HIT Solutions
10.4.4.2 Initiatives for Oncology Informatics
10.4.4.3 Market Dynamics
10.4.5 Australia
10.4.5.1 Degree of Adoption of EHR
10.4.5.2 Market Dynamics
10.4.6 Rest-of-Asia-Pacific
10.4.6.1 Degree of Adoption of HIT Solutions in New Zealand
10.4.6.2 Degree of Adoption of HIT Solutions in Malaysia
10.4.6.3 Degree of Adoption of HIT Solutions in Singapore
10.4.6.4 Market Dynamics
10.5 Rest-of-the-World
10.5.1 U.A.E.
10.5.1.1 Degree of Adoption of HIT Solutions
10.5.1.2 Challenges
10.5.1.3 Market Dynamics
10.5.2 Saudi Arabia
10.5.2.1 Degree of Adoption of HIT Solutions
10.5.2.2 Market Opportunities
10.5.3 Brazil
10.5.4 Mexico
10.5.5 South Africa
10.5.6 Rest-of-Rest-of-the-World
11 COMPANY PROFILES
11.1 Cerner Corporation
11.1.1 Company Overview
11.1.2 Role of Cerner Corporation in Global Oncology Informatics Market
11.1.3 Product Offerings
11.1.4 Financials
11.1.5 Key Insights about Financial Health of the Company
11.1.6 Recent Developments
11.1.7 SWOT Analysis
11.2 Change Healthcare
11.2.1 Company Overview
11.2.2 Role of Change Healthcare in Global Oncology Informatics Market
11.2.3 Product Offerings
11.2.4 Recent Key Developments
11.2.5 SWOT Analysis
11.3 Elekta AB
11.3.1 Company Overview
11.3.2 Role of Elekta AB in Global Oncology Informatics Market
11.3.3 Product Offerings
11.3.4 Financials
11.3.5 Key Insights about Financial Health of the Company
11.3.6 Recent Key Developments
11.3.7 SWOT Analysis
11.4 F. Hoffmann-La Roche Ltd
11.4.1 Company Overview
11.4.2 Role of F. Hoffmann-La Roche Ltd in Global Oncology Informatics Market
11.4.3 Product Offering
11.4.4 Financials
11.4.5 Key Insights about Financial Health of the Company
11.4.6 Recent Developments
11.4.7 SWOT Analysis
11.5 Hologic, Inc.
11.5.1 Company Overview
11.5.2 Role of Hologic, Inc. in Global Oncology Informatics Market
11.5.3 Product Offerings
11.5.4 Financials
11.5.5 Key Insights about Financial Health of the Company
11.5.6 Recent Developments
11.5.7 SWOT Analysis
11.6 IBM Corporation
11.6.1 Company Overview
11.6.2 Role of IBM Corporation in Global Oncology Informatics Market
11.6.3 Product Offerings
11.6.4 Financials
11.6.5 Key Insights about Financial Health of the Company
11.6.6 Recent Developments
11.6.7 SWOT Analysis
11.7 Inspirata, Inc.
11.7.1 Company Overview
11.7.2 Role of Inspirata, Inc. in Global Oncology Informatics Market
11.7.3 Product Offerings
11.7.4 Recent Key Developments
11.7.5 SWOT Analysis
11.8 Koninklijke Philips N.V.
11.8.1 Company Overview
11.8.2 Role of Koninklijke Philips N.V. in Global Oncology Informatics Market
11.8.3 Product Offerings
11.8.4 Financials
11.8.5 Key Insights about Financial Health of the Company
11.8.6 Recent Developments
11.8.7 SWOT Analysis
11.9 Laboratory Corporation of America Holdings
11.9.1 Company Overview
11.9.2 Role of Laboratory Corporation of America Holdings in Global Oncology Informatics Market
11.9.3 Product Offerings
11.9.4 Financials
11.9.5 Recent Key Developments
11.9.6 SWOT Analysis
11.10 McKesson Corporation
11.10.1 Company Overview
11.10.2 Role of McKesson Corporation in Global Oncology Informatics Market
11.10.3 Product Offerings
11.10.4 Financials
11.10.5 Key Insights about Financial Health of the Company
11.10.6 Recent Development
11.10.7 SWOT Analysis
11.11 MIM Software, Inc.
11.11.1 Company Overview
11.11.2 Role of MIM Software, Inc. in Global Oncology Informatics Market
11.11.3 Product Offerings
11.11.4 Recent Key Developments
11.11.5 SWOT Analysis
11.12 Oncology Analytics, Inc
11.12.1 Company Overview
11.12.2 Role of Oncology Analytics, Inc.in Global Oncology Informatics Market
11.12.3 Product Offerings
11.12.4 Recent Developments
11.12.5 SWOT Analysis
11.13 PerkinElmer, Inc.
11.13.1 Company Overview
11.13.2 Role of PerkinElmer Inc, in Global Oncology Informatics Market
11.13.3 Product Offerings
11.13.4 Financials
11.13.5 Key Insights about Financial Health of the Company
11.13.6 Recent Developments
11.13.7 SWOT Analysis
11.14 RELX Group
11.14.1 Company Overview
11.14.2 Role of RELX Group in Global Oncology Informatics Market
11.14.3 Product Offerings
11.14.4 Financials
11.14.5 Recent Developments
11.14.6 SWOT Analysis
11.15 Sirenas, LLC
11.15.1 Company Overview
11.15.2 Role of Sirenas, LLC in Global Oncology Informatics Market
11.15.3 Product Offerings
11.15.4 Recent Key Developments
11.15.5 SWOT Analysis
11.16 UnitedHealth Group, Inc
11.16.1 Company Overview
11.16.2 Role of UnitedHealth Group, Inc in Global Oncology Informatics Market
11.16.3 Product Offerings for Oncology Informatics Market
11.16.4 Financials
11.16.5 Recent Developments
11.16.6 SWOT Analysis
11.17 Varian Medical Systems, Inc
11.17.1 Company Overview
11.17.2 Role of Varian Medical Systems, Inc. in Global Oncology Informatics Market
11.17.3 Product Offerings
11.17.4 Financials
11.17.5 Key Insights about Financial Health of the Company
11.17.6 Recent Developments
11.17.7 SWOT Analysis
LIST OF TABLES
Table 1: Products for End Users as per Area of Usage
Table 2: Market Share of Different End Users, 2018 & 2025
Table 2.1: EHR Systems Meeting ASCO-Defined Criteria
Table 2.2: Comparison Between Different EHR Pricing Models
Table 2.3: Pricing of Different Medical Oncology EHRs for Different Practice Sizes
Table 5.1: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in North America
Table 5.2: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Europe
Table 5.3: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Asia-Pacific
Table 5.4: Number of Patents Granted Across Different Regions
Table 6.1: Partnerships and Collaborations, 2017-2019
Table 6.2: Product Launches and Upgradations, 2017-2019
Table 6.3: Mergers and Acquisitions, 2017-2019
Table 6.4: Business Expansion, 2016-2019
Table 6.5: Awards/Certifications/Funding/Approvals, 2017-2019
Table 6.6: Providers of Oncology Informatics Products
Table 7.1: Country-Wise Analysis of Adverse Events, 2016
Table 8.1: Description of Various Oncology EHR
Table 8.2: Global Installation of Oncology EHR in Leading Organizations
Table 8.3: Oncology PHM and its Product Description
Table 8.4: Oncology CDSS, Product Description
Table 8.5: Application Areas of CDSS in Oncology
Table 8.6: Global Installation of Oncology CDSS in Leading Organizations
Table 8.7: Oncology Drug Discovery and Development Informatics and Product Description
Table 8.8: Global Installation of Oncology Drug Discovery and Development in Leading Organizations
Table 8.9: Oncology Image Analytics and Product Description
Table 10.1: Adoption Rate of EHR Across Specialties in the U.S. Healthcare System, 2017
Table 10.2: Other European Countries Market Share in 2018 and 2025
Table 10.3: Presence of EHR and EMR Systems Across Different Private and Public Hospitals
Table 11.1: Recent Developments: Cerner Corporation
Table 11.2: Recent Developments: Change Healthcare Corporation
Table 11.3: Recent Developments: Elekta AB
Table 11.4: Recent Developments, F. Hoffmann- La Roche Ltd
Table 11.5: Recent Developments: Hologic, Inc.
Table 11.6: Recent Developments: IBM Corporation
Table 11.7: Recent Developments: Inspirata, Inc.
Table 11.8: Recent Developments: Koninklijke Philips N.V.
Table 11.9: Recent Developments: Laboratory Corporation of America Holdings
Table 11.10: Recent Developments: McKesson Corporation
Table 11.11: Recent Developments, MIM Software, Inc.
Table 11.12: Recent Developments: Oncology Analytics, Inc.
Table 11.13: Recent Developments: PerkinElmer, Inc.
Table 11.14: Recent Developments: RELX Group
Table 11.15: Recent Developments: Sirenas, LLC
Table 11.16: Recent Developments: United Health Group, Inc.
Table 11.17: Recent Developments: Varian Medical Systems, Inc.
Table 1: Products for End Users as per Area of Usage
Table 2: Market Share of Different End Users, 2018 & 2025
Table 2.1: EHR Systems Meeting ASCO-Defined Criteria
Table 2.2: Comparison Between Different EHR Pricing Models
Table 2.3: Pricing of Different Medical Oncology EHRs for Different Practice Sizes
Table 5.1: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in North America
Table 5.2: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Europe
Table 5.3: Regulatory Framework/Act/Policy/Consortium/Standard for Oncology Informatics Market in Asia-Pacific
Table 5.4: Number of Patents Granted Across Different Regions
Table 6.1: Partnerships and Collaborations, 2017-2019
Table 6.2: Product Launches and Upgradations, 2017-2019
Table 6.3: Mergers and Acquisitions, 2017-2019
Table 6.4: Business Expansion, 2016-2019
Table 6.5: Awards/Certifications/Funding/Approvals, 2017-2019
Table 6.6: Providers of Oncology Informatics Products
Table 7.1: Country-Wise Analysis of Adverse Events, 2016
Table 8.1: Description of Various Oncology EHR
Table 8.2: Global Installation of Oncology EHR in Leading Organizations
Table 8.3: Oncology PHM and its Product Description
Table 8.4: Oncology CDSS, Product Description
Table 8.5: Application Areas of CDSS in Oncology
Table 8.6: Global Installation of Oncology CDSS in Leading Organizations
Table 8.7: Oncology Drug Discovery and Development Informatics and Product Description
Table 8.8: Global Installation of Oncology Drug Discovery and Development in Leading Organizations
Table 8.9: Oncology Image Analytics and Product Description
Table 10.1: Adoption Rate of EHR Across Specialties in the U.S. Healthcare System, 2017
Table 10.2: Other European Countries Market Share in 2018 and 2025
Table 10.3: Presence of EHR and EMR Systems Across Different Private and Public Hospitals
Table 11.1: Recent Developments: Cerner Corporation
Table 11.2: Recent Developments: Change Healthcare Corporation
Table 11.3: Recent Developments: Elekta AB
Table 11.4: Recent Developments, F. Hoffmann- La Roche Ltd
Table 11.5: Recent Developments: Hologic, Inc.
Table 11.6: Recent Developments: IBM Corporation
Table 11.7: Recent Developments: Inspirata, Inc.
Table 11.8: Recent Developments: Koninklijke Philips N.V.
Table 11.9: Recent Developments: Laboratory Corporation of America Holdings
Table 11.10: Recent Developments: McKesson Corporation
Table 11.11: Recent Developments, MIM Software, Inc.
Table 11.12: Recent Developments: Oncology Analytics, Inc.
Table 11.13: Recent Developments: PerkinElmer, Inc.
Table 11.14: Recent Developments: RELX Group
Table 11.15: Recent Developments: Sirenas, LLC
Table 11.16: Recent Developments: United Health Group, Inc.
Table 11.17: Recent Developments: Varian Medical Systems, Inc.
LIST OF FIGURES
Figure 1: Global Oncology Informatics Market, 2018-2025
Figure 2: Market Dynamics
Figure 3: Share of Different Strategies
Figure 4: Market Share of Different Regions, 2019-2025
Figure 2.1: Comparison of Direct Cost Between SaaS and On-Premise-Based Systems
Figure 2.2: Comparison of Subscription License and Perpetual License Fee Structure
Figure 3.1: Global Oncology Informatics Market: Market Segmentation
Figure 4.1: Global Oncology Informatics Market Methodology
Figure 4.2: Primary Research
Figure 4.3: Secondary Research
Figure 4.4: Data Triangulation
Figure 4.5: Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.6: Assumptions and Limitations
Figure 4.7: Factors Considered for Data Prediction and Modeling
Figure 5.1: Advantages of Oncology Informatics
Figure 6.1: Global Oncology Informatics Market Share (by Company)
Figure 6.2: Global Oncology Informatics Market (Key development and strategies)
Figure 6.3: Partnerships and Collaborations Share (by Company)
Figure 6.4: Product Launches and Upgradations (by Company)
Figure 6.5: Mergers and Acquisitions (by Company)
Figure 6.6: Other Activities (Share)
Figure 6.7: Product Mapping Analysis- Global Oncology Informatics Market
Figure 8.1: Global Oncology Informatics Market, by Type
Figure 8.2: Global Oncology EHR Market, 2018-2025
Figure 8.3: Features of Oncology EHR
Figure 8.4: Investment Plans of Healthcare Providers and Payers for Population Health Management Strategies
Figure 8.5: Workflow of Population Health Management Strategy
Figure 8.6: Global Oncology PHM Market, 2018-2025
Figure 8.7: Features of Oncology PHM
Figure 8.8: Workflow of CDSS in Clinical Setting
Figure 8.9: Global Oncology CDSS Market, 2018-2025
Figure 8.10: Features of Oncology CDSS
Figure 8.11: Global Oncology Drug Discovery and Development Informatics Market, 2018-2025
Figure 8.12: Global Oncology Image Analytics Market, 2018-2025
Figure 9.1: End Users of Oncology Informatics Market
Figure 9.2: Global Oncology Informatics Market (Pharmaceutical Industry), 2018-2025
Figure 9.3: Global Oncology Informatics Market (Life Science Industry), 2018-2025
Figure 9.4: Global Oncology Informatics Market (CROs), 2018-2025
Figure 9.5: Global Oncology Informatics Market (Academic Institutes and Research Centers), 2018-2025
Figure 9.6: Global Oncology Informatics Market (Hospitals and Other Care Facilities), 2018-2025
Figure 10.1: Region-Wise Analysis of Global Oncology Informatics Market, 2018 and 2025
Figure 10.2: North America Oncology Informatics Market, 2018-2025
Figure 10.3: Factors Influencing North America Oncology Informatics Market
Figure 10.4: U.S. Oncology Informatics Market, 2018-2025
Figure 10.5: Canada Oncology Informatics Market, 2018-2025
Figure 10.6: Prevalence Rate of Various Chronic Diseases in Canada
Figure 10.7: Europe Oncology Informatics Market, 2018-2025
Figure 10.8: Initiatives in Europe
Figure 10.9: Factors Influencing Oncology Informatics in Europe
Figure 10.10: Germany Oncology Informatics Market, 2018-2025
Figure 10.11: Cancer Cases in Germany, by Type, 2018
Figure 10.12: Distribution of Medical Treatment Errors in Germany, by Error Type, 2016,
Figure 10.13: U.K. Oncology Informatics Market, 2018-2025
Figure 10.14: Cancer Cases in U.K., by Type, 2018
Figure 10.15: France Oncology Informatics Market, 2018-2025
Figure 10.16: Cancer Cases in France, by Type
Figure 10.17: Spain Oncology Informatics Market, 2018-2025
Figure 10.18: Cancer Cases in Spain, by Type, 2018
Figure 10.19: Italy Oncology Informatics Market, 2018-2025
Figure 10.20: Cancer Cases in Italy, by Type, 2018
Figure 10.21: Other European Countries Oncology Informatics Market, 2018-2025
Figure 10.22: Asia-Pacific Oncology Informatics Market, 2018-2025
Figure 10.23: Factors Influencing Oncology Informatics Market in Asia-Pacific
Figure 10.24: South Korea Oncology Informatics Market, 2018-2025
Figure 10.25: Japan Oncology Informatics Marker, 2018-2025
Figure 10.26: China Oncology Informatics Marker, 2018-2025
Figure 10.27: India Oncology Informatics Market, 2018-2025
Figure 10.28: Australia Oncology Informatics Market, 2018-2025
Figure 10.29: Other Asia-Pacific Countries Oncology Informatics Marker, 2018-2025
Figure 10.30: Rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 10.31: Factors Influencing the Rest-of-the-World Oncology Informatics Market
Figure 10.32: U.A.E. Oncology Informatics Market, 2018-2025
Figure 10.33: Saudi Arabia Oncology Informatics Market, 2018-2025
Figure 10.34: Brazil Oncology Informatics Market, 2018-2025
Figure 10.35: Mexico Oncology Informatics Market, 2018-2025
Figure 10.36: South Africa Oncology Informatics Market, 2018-2025
Figure 10.37: Rest-of-rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 11.1: Cerner Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.2: Cerner Corporation: Overall Financials, 2016-2018
Figure 11.3: Cerner Corporation.: Revenue (by Segment), 2016-2018
Figure 11.4: Cerner Corporation.: Revenue (by Region), 2016-2018
Figure 11.5: Cerner Corporation: R&D Expenditure, 2016-2018
Figure 11.6: Change Healthcare: Product Portfolio for Oncology Informatics Market
Figure 11.7: Elekta AB: Product Portfolio for Oncology Informatics Market
Figure 11.8: Elekta AB: Overall Financials ,2016-2018
Figure 11.9: Elekta AB: Revenue (by Segment) ,2016-2018
Figure 11.10: Elekta AB: Revenue (by Region) ,2016-2018
Figure 11.11: Elekta AB: R&D Expenditure, 2016-2018
Figure 11.12: F. Hoffmann-La Roche Ltd: Product Portfolio for Oncology Informatics Market
Figure 11.13: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 11.14: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2016-2018
Figure 11.15: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2017-2018
Figure 11.16: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016
Figure 11.17: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
Figure 11.18: Hologic, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.19: Hologic, Inc.: Overall Financials ,2017-2019
Figure 11.20: Hologic, Inc.: Revenue (by Business Segment) ,2017-2019
Figure 11.21: Hologic, Inc.: Revenue (by Region) ,2017-2019
Figure 11.22: Hologic, Inc.: R&D Expenditure, 2017-2019
Figure 11.23: IBM Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.24: IBM Corporation: Overall Financials ,2016-2018
Figure 11.25: IBM Corporation: Revenue (by Business Segment) ,2016-2018
Figure 11.26: IBM Corporation: Revenue (by Region) ,2016-2018
Figure 11.27: IBM Corporation: R&D Expenditure, 2016-2018
Figure 11.28: Inspirata, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.29: Koninklijke Philips N.V.: Product Portfolio for Oncology Informatics Market
Figure 11.30: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 11.31: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
Figure 11.32: Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
Figure 11.33: Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
Figure 11.34: Laboratory Corporation of America Holdings: Product Portfolio for Oncology Informatics Market
Figure 11.35: Laboratory Corporation of America Holdings: Overall Financials ,2016-2018
Figure 11.36: Laboratory Corporation of America Holdings: Revenue (by Segment) ,2016-2018
Figure 11.37: Laboratory Corporation of America Holdings: Revenue (by Region) , 2016-2018
Figure 11.38: McKesson Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.39: McKesson Corporation: Overall Financials, 2016-2018
Figure 11.40: McKesson Corporation: Revenue (by Segment), 2016-2018
Figure 11.41: McKesson Corporation: Revenue (by Region), 2016-2018
Figure 11.42: McKesson Corporation: R&D Expenditure, 2016-2018
Figure 11.43: MIM Software, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.44: Oncology Analytics, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.45: PerkinElmer, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.46: PerkinElmer, Inc.: Overall Financials, 2016-2018
Figure 11.47: PerkinElmer, Inc.: Revenue (by Segment), 2016-2018
Figure 11.48: PerkinElmer, Inc.: Revenue (by Region), 2016-2017
Figure 11.49: PerkinElmer, Inc.: Revenue (by Region), 2018
Figure 11.50: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 11.51: RELX Group: Product Portfolio for Oncology Informatics Market
Figure 11.52: RELX Group: Overall Financials, 2016-2018
Figure 11.53: RELX Group: Revenue (by Segment), 2016-2018
Figure 11.54: RELX Group: Revenue (by Region), 2016-2018
Figure 11.55: Sirenas, LLC: Product Portfolio for Oncology Informatics Market
Figure 11.56: UnitedHealth Group Inc: Product Portfolio for Oncology Informatics Market
Figure 11.57: UnitedHealth Group, Inc.: Overall Financials, 2016-2018
Figure 11.58: UnitedHealth Group, Inc.: Revenue (by Segment), 2016-2018
Figure 11.59: United Health Group, Inc.: Revenue (by Region), 2016-2018
Figure 11.60: Varian Medical Systems, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.61: Varian Medical Systems, Inc.: Overall Financials, 2016-2018
Figure 11.62: Varian Medical Systems, Inc.: Revenue (by Segment), 2016-2018
Figure 11.63: Varian Medical Systems, Inc.: Revenue (by Region), 2016-2018
Figure 11.64: Varian Medical Systems, Inc.: R&D Expenditure, 2016-2018
Figure 1: Global Oncology Informatics Market, 2018-2025
Figure 2: Market Dynamics
Figure 3: Share of Different Strategies
Figure 4: Market Share of Different Regions, 2019-2025
Figure 2.1: Comparison of Direct Cost Between SaaS and On-Premise-Based Systems
Figure 2.2: Comparison of Subscription License and Perpetual License Fee Structure
Figure 3.1: Global Oncology Informatics Market: Market Segmentation
Figure 4.1: Global Oncology Informatics Market Methodology
Figure 4.2: Primary Research
Figure 4.3: Secondary Research
Figure 4.4: Data Triangulation
Figure 4.5: Bottom-Up Approach (Segment-Wise Analysis)
Figure 4.6: Assumptions and Limitations
Figure 4.7: Factors Considered for Data Prediction and Modeling
Figure 5.1: Advantages of Oncology Informatics
Figure 6.1: Global Oncology Informatics Market Share (by Company)
Figure 6.2: Global Oncology Informatics Market (Key development and strategies)
Figure 6.3: Partnerships and Collaborations Share (by Company)
Figure 6.4: Product Launches and Upgradations (by Company)
Figure 6.5: Mergers and Acquisitions (by Company)
Figure 6.6: Other Activities (Share)
Figure 6.7: Product Mapping Analysis- Global Oncology Informatics Market
Figure 8.1: Global Oncology Informatics Market, by Type
Figure 8.2: Global Oncology EHR Market, 2018-2025
Figure 8.3: Features of Oncology EHR
Figure 8.4: Investment Plans of Healthcare Providers and Payers for Population Health Management Strategies
Figure 8.5: Workflow of Population Health Management Strategy
Figure 8.6: Global Oncology PHM Market, 2018-2025
Figure 8.7: Features of Oncology PHM
Figure 8.8: Workflow of CDSS in Clinical Setting
Figure 8.9: Global Oncology CDSS Market, 2018-2025
Figure 8.10: Features of Oncology CDSS
Figure 8.11: Global Oncology Drug Discovery and Development Informatics Market, 2018-2025
Figure 8.12: Global Oncology Image Analytics Market, 2018-2025
Figure 9.1: End Users of Oncology Informatics Market
Figure 9.2: Global Oncology Informatics Market (Pharmaceutical Industry), 2018-2025
Figure 9.3: Global Oncology Informatics Market (Life Science Industry), 2018-2025
Figure 9.4: Global Oncology Informatics Market (CROs), 2018-2025
Figure 9.5: Global Oncology Informatics Market (Academic Institutes and Research Centers), 2018-2025
Figure 9.6: Global Oncology Informatics Market (Hospitals and Other Care Facilities), 2018-2025
Figure 10.1: Region-Wise Analysis of Global Oncology Informatics Market, 2018 and 2025
Figure 10.2: North America Oncology Informatics Market, 2018-2025
Figure 10.3: Factors Influencing North America Oncology Informatics Market
Figure 10.4: U.S. Oncology Informatics Market, 2018-2025
Figure 10.5: Canada Oncology Informatics Market, 2018-2025
Figure 10.6: Prevalence Rate of Various Chronic Diseases in Canada
Figure 10.7: Europe Oncology Informatics Market, 2018-2025
Figure 10.8: Initiatives in Europe
Figure 10.9: Factors Influencing Oncology Informatics in Europe
Figure 10.10: Germany Oncology Informatics Market, 2018-2025
Figure 10.11: Cancer Cases in Germany, by Type, 2018
Figure 10.12: Distribution of Medical Treatment Errors in Germany, by Error Type, 2016,
Figure 10.13: U.K. Oncology Informatics Market, 2018-2025
Figure 10.14: Cancer Cases in U.K., by Type, 2018
Figure 10.15: France Oncology Informatics Market, 2018-2025
Figure 10.16: Cancer Cases in France, by Type
Figure 10.17: Spain Oncology Informatics Market, 2018-2025
Figure 10.18: Cancer Cases in Spain, by Type, 2018
Figure 10.19: Italy Oncology Informatics Market, 2018-2025
Figure 10.20: Cancer Cases in Italy, by Type, 2018
Figure 10.21: Other European Countries Oncology Informatics Market, 2018-2025
Figure 10.22: Asia-Pacific Oncology Informatics Market, 2018-2025
Figure 10.23: Factors Influencing Oncology Informatics Market in Asia-Pacific
Figure 10.24: South Korea Oncology Informatics Market, 2018-2025
Figure 10.25: Japan Oncology Informatics Marker, 2018-2025
Figure 10.26: China Oncology Informatics Marker, 2018-2025
Figure 10.27: India Oncology Informatics Market, 2018-2025
Figure 10.28: Australia Oncology Informatics Market, 2018-2025
Figure 10.29: Other Asia-Pacific Countries Oncology Informatics Marker, 2018-2025
Figure 10.30: Rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 10.31: Factors Influencing the Rest-of-the-World Oncology Informatics Market
Figure 10.32: U.A.E. Oncology Informatics Market, 2018-2025
Figure 10.33: Saudi Arabia Oncology Informatics Market, 2018-2025
Figure 10.34: Brazil Oncology Informatics Market, 2018-2025
Figure 10.35: Mexico Oncology Informatics Market, 2018-2025
Figure 10.36: South Africa Oncology Informatics Market, 2018-2025
Figure 10.37: Rest-of-rest-of-the-World Oncology Informatics Market, 2018-2025
Figure 11.1: Cerner Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.2: Cerner Corporation: Overall Financials, 2016-2018
Figure 11.3: Cerner Corporation.: Revenue (by Segment), 2016-2018
Figure 11.4: Cerner Corporation.: Revenue (by Region), 2016-2018
Figure 11.5: Cerner Corporation: R&D Expenditure, 2016-2018
Figure 11.6: Change Healthcare: Product Portfolio for Oncology Informatics Market
Figure 11.7: Elekta AB: Product Portfolio for Oncology Informatics Market
Figure 11.8: Elekta AB: Overall Financials ,2016-2018
Figure 11.9: Elekta AB: Revenue (by Segment) ,2016-2018
Figure 11.10: Elekta AB: Revenue (by Region) ,2016-2018
Figure 11.11: Elekta AB: R&D Expenditure, 2016-2018
Figure 11.12: F. Hoffmann-La Roche Ltd: Product Portfolio for Oncology Informatics Market
Figure 11.13: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
Figure 11.14: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2016-2018
Figure 11.15: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2017-2018
Figure 11.16: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2016
Figure 11.17: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
Figure 11.18: Hologic, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.19: Hologic, Inc.: Overall Financials ,2017-2019
Figure 11.20: Hologic, Inc.: Revenue (by Business Segment) ,2017-2019
Figure 11.21: Hologic, Inc.: Revenue (by Region) ,2017-2019
Figure 11.22: Hologic, Inc.: R&D Expenditure, 2017-2019
Figure 11.23: IBM Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.24: IBM Corporation: Overall Financials ,2016-2018
Figure 11.25: IBM Corporation: Revenue (by Business Segment) ,2016-2018
Figure 11.26: IBM Corporation: Revenue (by Region) ,2016-2018
Figure 11.27: IBM Corporation: R&D Expenditure, 2016-2018
Figure 11.28: Inspirata, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.29: Koninklijke Philips N.V.: Product Portfolio for Oncology Informatics Market
Figure 11.30: Koninklijke Philips N.V.: Overall Financials, 2016-2018
Figure 11.31: Koninklijke Philips N.V.: Revenue (by Segment), 2016-2018
Figure 11.32: Koninklijke Philips N.V.: Revenue (by Region), 2016-2018
Figure 11.33: Koninklijke Philips N.V.: R&D Expenditure, 2016-2018
Figure 11.34: Laboratory Corporation of America Holdings: Product Portfolio for Oncology Informatics Market
Figure 11.35: Laboratory Corporation of America Holdings: Overall Financials ,2016-2018
Figure 11.36: Laboratory Corporation of America Holdings: Revenue (by Segment) ,2016-2018
Figure 11.37: Laboratory Corporation of America Holdings: Revenue (by Region) , 2016-2018
Figure 11.38: McKesson Corporation: Product Portfolio for Oncology Informatics Market
Figure 11.39: McKesson Corporation: Overall Financials, 2016-2018
Figure 11.40: McKesson Corporation: Revenue (by Segment), 2016-2018
Figure 11.41: McKesson Corporation: Revenue (by Region), 2016-2018
Figure 11.42: McKesson Corporation: R&D Expenditure, 2016-2018
Figure 11.43: MIM Software, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.44: Oncology Analytics, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.45: PerkinElmer, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.46: PerkinElmer, Inc.: Overall Financials, 2016-2018
Figure 11.47: PerkinElmer, Inc.: Revenue (by Segment), 2016-2018
Figure 11.48: PerkinElmer, Inc.: Revenue (by Region), 2016-2017
Figure 11.49: PerkinElmer, Inc.: Revenue (by Region), 2018
Figure 11.50: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
Figure 11.51: RELX Group: Product Portfolio for Oncology Informatics Market
Figure 11.52: RELX Group: Overall Financials, 2016-2018
Figure 11.53: RELX Group: Revenue (by Segment), 2016-2018
Figure 11.54: RELX Group: Revenue (by Region), 2016-2018
Figure 11.55: Sirenas, LLC: Product Portfolio for Oncology Informatics Market
Figure 11.56: UnitedHealth Group Inc: Product Portfolio for Oncology Informatics Market
Figure 11.57: UnitedHealth Group, Inc.: Overall Financials, 2016-2018
Figure 11.58: UnitedHealth Group, Inc.: Revenue (by Segment), 2016-2018
Figure 11.59: United Health Group, Inc.: Revenue (by Region), 2016-2018
Figure 11.60: Varian Medical Systems, Inc.: Product Portfolio for Oncology Informatics Market
Figure 11.61: Varian Medical Systems, Inc.: Overall Financials, 2016-2018
Figure 11.62: Varian Medical Systems, Inc.: Revenue (by Segment), 2016-2018
Figure 11.63: Varian Medical Systems, Inc.: Revenue (by Region), 2016-2018
Figure 11.64: Varian Medical Systems, Inc.: R&D Expenditure, 2016-2018
